X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

How drug importation schemes could increase U.S. law enforcement burdens

By Allyson Funk  |    March 16, 2017
In recent weeks, we’ve explored some of the dangers of importation for patients and how medicines purchased online can be fake. But what would importation schemes mean for U.S. law enforcement?   Read More

Case Study: How one online pharmacy knowingly endangered U.S. consumers

By Nicole Longo  |    March 2, 2017
We recently looked at what actually happens when a patient orders a medicine through an online Canadian pharmacy and how the product delivered may not be what the patient ordered. Today, we’re...   Read More

Why drug importation threatens patient safety

By Allyson Funk  |    February 28, 2017
Counterfeit drug manufacturing and trafficking is a multi-billion dollar business. Legislative proposals to allow importation of potentially counterfeit and substandard drugs into the United...   Read More

Fact Check Friday: The truth about drug importation and patient safety

By Allyson Funk  |    February 24, 2017
This week on Fact Check Friday, we’re discussing the truth about proposals to allow the importation of medicines from other countries and what these proposals mean for patients. MYTH: Importation...   Read More

What you don’t know about importation from Canada

By Allyson Funk  |    February 17, 2017
Proposals to allow the importation of prescription medicines from Canada ignore the dangerous threat to patients of counterfeit and adulterated medicines. What actually happens when a patient...   Read More

Discovery of counterfeit hepatitis C drug is another example of why importation is bad for patients

By Nicole Longo  |    February 13, 2017
The manufacturing and trafficking of counterfeit drugs is not just a U.S. concern but a growing threat globally. Governments around the world are working together to try to prevent these fake...   Read More

Stopping opioid abuse

By Anne McDonald Pritchett, PhD  |    May 6, 2016
According to the U.S. Centers for Disease Control and Prevention (CDC), more than 14,000 people died from overdoses involving opioids in 2014—a four-fold increase since 2009. The agency has...   Read More

Phased-in approach offers best hope for FDA’s proposed quality metrics program

By Camille Jackson  |    April 7, 2016
In July 2015, the U.S. Food and Drug Administration (FDA) issued draft guidance for industry requiring manufacturers to provide certain manufacturing data on an annual basis. The FDA’s Center for...   Read More

Research doesn’t end on a medicine’s approval

By Andrew Powaleny  |    March 16, 2016
Research is a critical part of the development of new medicines, but it doesn’t stop once the medicine is approved by the U.S. Food and Drug Administration (FDA).  In fact, that’s when...   Read More

MyOldMeds campaign launches in Massachusetts

By Priscilla VanderVeer  |    February 25, 2016
Every day in Massachusetts, four people die from an opioid overdose. It is one of the most difficult public health challenges facing the Commonwealth, and the country. Prescription drug abuse...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates